4//SEC Filing
CDK Global, Inc. 4
Accession 0000950142-17-000569
CIK 0001609702operating
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 7:01 PM ET
Size
16.2 KB
Accession
0000950142-17-000569
Insider Transaction Report
Form 4
Karp Robert N.
VP & President, ARNA
Transactions
- Exercise/Conversion
Common Stock
2017-03-08$20.24/sh+14,476$293,052→ 85,274.892 total - Exercise/Conversion
Common Stock
2017-03-08$21.72/sh+22,059$479,121→ 107,333.892 total - Sale
Common Stock
2017-03-08$66.47/sh−46,185$3,070,102→ 61,148.892 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-03-08−14,476→ 0 totalExercise: $20.24Exp: 2022-01-25→ Common Stock (14,476 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2017-03-08−22,059→ 0 totalExercise: $21.72Exp: 2023-01-24→ Common Stock (22,059 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2017-03-08−9,650→ 0 totalExercise: $17.96Exp: 2021-02-07→ Common Stock (9,650 underlying) - Exercise/Conversion
Common Stock
2017-03-08$17.96/sh+9,650$173,314→ 70,798.892 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple open market transactions at prices ranging from $66.30 to $66.60, inclusive. The report person undertakes to provide to CDK Global, Inc., a security holder thereof, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1).
- [F2]Grant has a graded vesting schedule. Date Exercisable varied for each vesting tranche.
Documents
Issuer
CDK Global, Inc.
CIK 0001609702
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001609702
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 7:01 PM ET
- Size
- 16.2 KB